sanofi Home > OurScience > R&DFocusAreas > Immunology R&D Immunology and Inflammation R&D We're an emerging leader in immunology, poised to transform medicine by rebalancing the immune responses that cause systemic, chronic diseases. Illustration of substances being released at a cell’s surface leading to inflammation.“When it comes to \ immunology, we're thinking bigger and digging deeper than a single drug.” er, Dietmar Berger Global Head of R&D Illustration of inflammation ata cell’s surface Our immunology pipelineOur teams use real-world, molecular, and clinical data to advance precision medicine, and investigate: + pathways common to systemic diseases like asthma and atopic dermatitis + peripheral inflammatory diseases like rheumatoid arthritis + autoimmune challenges in type | diabetes and cancer Follow the Science Taking Down Type 2 Inflammatory Disease We're working to tame over-active immune responses that drive systemic, chronic diseases. Read the article —> From Wearables to Invisibles: Studying Sleep Using Al and wireless tech, we're helping people participate in research from home. Read the article —>REGAINing Control of Asthma We're leveraging smart devices to understand the patient experience. Readthe article —> Type 2 inflammationOur goal: to give people their lives back by calming excessive inflammation ability to fight infection. out compromising their With our partner Regeneron, we study how blocking two interleukins! can help calm type 2 inflammation, a driver of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, and other conditions. More about type 2 inflammation > Beyond type 2 inflammation Precision Immunology Checkpoint Immunology Single-cell genomics, genetics, and How can we restore the delicate balance proteomics help us understand exactly what between a protective immune response and makes patients different from one another. destructive autoimmunity? Complement System Can we stop a cascade of inflammation without compromising immunity, by blocking one protein?> More about ImmunologyYour Health: Immunology On Track to Lead in Immunoscience Seemore ~ Read the article > Careers in R&D: Virginia Savova Watch the video (7 References 1. Mifflin L, Ofengeim D, Yuan J (2020) Nat Rev Drug Discov 19:553-571; DOI: 10.1038/s41573-020-O07I-y 2. Calabrese LH, et al. (2020) J Autoimmun 115:102546; DOI: 10.1016/},jaut.2020102546, 3. Nikitin PA, et al. (2019) J Immunol 202:1200-1209; DOI: 10.4049/jimmunol:1800998Page updated August 2023 Continue to Immunology Partnering > MAT-GLB-2004283 v-2.0 6/2023 Contact Legal notice Privacy & data protection Cookies Policy Code of Conduct Our publications Sitemap Directory Accessibility: partial complianceSanofi Today © Sanofi 2004-2023 - All rights reserved